Cart
sales@molnova.com
BT-11
CAS No. 1912399-75-7
BT-11( —— )
Catalog No. M17401 CAS No. 1912399-75-7
BT-11 is an orally available LANCL2 binding compound. It is used in the therapy of inflammatory bowel disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 77 | In Stock |
|
| 5MG | 120 | In Stock |
|
| 10MG | 179 | In Stock |
|
| 25MG | 323 | In Stock |
|
| 50MG | 588 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBT-11
-
NoteResearch use only, not for human use.
-
Brief DescriptionBT-11 is an orally available LANCL2 binding compound. It is used in the therapy of inflammatory bowel disease.
-
DescriptionBT-11 is an orally available LANCL2 binding compound. It is used in the therapy of inflammatory bowel disease.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetJAK
-
RecptorLANCL2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1912399-75-7
-
Formula Weight528.56
-
Molecular FormulaC30H24N8O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 30 mg/mL; 56.76 mM
-
SMILESO=C(N1CCN(C(=O)c2nc(c3nc4ccccc4[nH]3)ccc2)CC1)c1nc(c2nc3ccccc3[nH]2)ccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Carbo A, et al. J Med Chem. 2016 Nov 23;59(22):10113-10126.
molnova catalog
related products
-
iJak-381
iJak-381 (iJak381) is a potent, selective inhalable and lung-restricted inhibitor of JAK1 with IC50 of 8.52 nM.
-
WHI-P97 HCl 211555-0...
WHI-P97 HCl is a potent and selective JAK-3 inhibitor.?WHI-P97 had an estimated Ki value of 0.09 microM from modeling studies and a measured IC50 value of 2.5 microM in EGFR kinase inhibition assays.?WHI-P97 effectively inhibited the in vitro invasiveness of EGFR-positive human cancer cells in a concentration-dependent manner.
-
PF-06700841 tosylate
PF-06700841 is a potent, selective TYK2/JAK1 kinase inhibitor that reduces IL-23 expression and directly attenuates IL-23 signaling via TYK2.
